Hypertension
Swapnil Hiremath
Department of Medicine, University of Ottawa, Ottawa, Canada
Search for more papers by this authorSwapnil Hiremath
Department of Medicine, University of Ottawa, Ottawa, Canada
Search for more papers by this authorJonathan C. Craig MBChB, DipCH, MMed(Clin Epi), PhD, FAHMS
Matthew Flinders Distinguished Professor Vice President and Executive Dean
College of Medicine and Public Health, Flinders University, Adelaide, Australia
Search for more papers by this authorDonald A. Molony MD
Professor of Medicine Distinguished Teaching Professor of the University of Texas System
Division of Renal Diseases and Hypertension AND Center for Clinical Research and Evidence-based Medicine, McGovern Medical School University of Texas, Houston, TX, USA
Search for more papers by this authorGiovanni F.M. Strippoli MD, PhD, MPH, MM (Epi)
Professor of Nephrology Adjunct Professor of Epidemiology
Department of Emergency and Organ Transplantation – University of Bari, Bari, Italy
School of Public Health, University of Sydney, Sydney, NSW, Australia
Search for more papers by this authorSummary
The kidneys are inextricably interwoven with high blood pressure (BP). Hypertension is called the silent killer in the lay media precisely because it is asymptomatic for the vast majority. An underappreciated aspect of the management of hyper tension is proper BP measurement. Inaccurate measurement will result in inappropriate treatment. Modern home BP devices use an oscillometric technique, and are cheap and easy to use. Variability is variably defined based on the time frame. Short-term variability refers to that seen on a 24-hour Ambulatory blood pressure monitoring whereas long-term refers to visit-to-visit variability. Masked hypertension deserves a separate mention since it follows, as a corollary of improper BP measurement, that it is underrecognized and potentially undertreated. Thiazide diuretics are the oldest class of BP lowering drugs which are still first-line agents. Device therapy has shown some promising results in recent years, but it is far from being ready for clinical use yet.
References
- Harlos , J. and Heidland , A. ( 1994 ). Hypertension as cause and consequence of renal disease in the 19th century . Am. J. Nephrol. 14 ( 4–6 ): 436 – 442 .
- Rose , G. ( 1985 ). Sick individuals and sick populations . Int. J. Epidemiol. 14 ( 1 ): 32 – 38 .
- Forouzanfar , M.H. , Liu , P. , Roth , G.A. et al. ( 2017 ). Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015 . JAMA 317 ( 2 ): 165 – 182 .
- Ettehad , D. , Emdin , C.A. , Kiran , A. et al. ( 2016 ). Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis . Lancet 387 ( 10022 ): 957 – 967 .
- Melville , S. and Byrd , J.B. ( 2018 ). Out-of-office blood pressure monitoring in 2018 . JAMA 320 ( 17 ): 1805 – 1806 .
- Kallioinen , N. , Hill , A. , Horswill , M.S. et al. ( 2017 ). Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review . J. Hypertens. 35 ( 3 ): 421 – 441 .
- Myers , M.G. , Godwin , M. , Dawes , M. et al. ( 2011 ). Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial . BMJ 342 : d286 .
- Leung , A.A. , Nerenberg , K. , Daskalopoulou , S.S. et al. ( 2016 ). Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension . Can. J. Cardiol. 32 ( 5 ): 569 – 588 .
- Lonn , E.M. , Bosch , J. , Lopez-Jaramillo , P. et al. ( 2016 ). Blood-pressure lowering in intermediate-risk persons without cardiovascular disease . N. Engl. J. Med. 374 ( 21 ): 2009 – 2020 .
- Wright , J.T. Jr. , Williamson , J.D. , Whelton , P.K. et al. ( 2015 ). A randomized trial of intensive versus standard blood-pressure control . N. Engl. J. Med. 373 ( 22 ): 2103 – 2116 .
- Cushman , W.C. , Evans , G.W. , Byington , R.P. et al. ( 2010 ). Effects of intensive blood-pressure control in type 2 diabetes mellitus . N. Engl. J. Med. 362 ( 17 ): 1575 – 1585 .
- Ruzicka , M. , Akbari , A. , Bruketa , E. et al. ( 2016 ). How accurate are home blood pressure devices in use? A cross-sectional study . PLoS One 11 ( 6 ): e0155677 .
- Ruzicka , M. and Hiremath , S. ( 2017 ). Accuracy—limiting factor of home blood pressure monitors? Am. J. Hypertens. 30 ( 7 ): 661 – 664 .
- Agarwal , R. , Bills , J.E. , Hecht , T.J. , and Light , R.P. ( 2011 ). Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis . Hypertension 57 ( 1 ): 29 – 38 .
- Omron , H. ( 2018 ). HeartGuide, the highly-anticipated first wearable blood pressure monitor from Omron . https://www.prnewswire.com/news-releases/heartguide-the-highly-anticipated-first-wearable-blood-pressure-monitor-from-omron-available-for-pre-order-on-december-20th-300769335.html (accessed 22 May 2021).
- Mena , L. , Pintos , S. , Queipo , N.V. et al. ( 2005 ). A reliable index for the prognostic significance of blood pressure variability . J. Hypertens. 23 ( 3 ): 505 – 511 .
- Chang , T.I. , Tabada , G.H. , Yang , J. et al. ( 2016 ). Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease . J. Hypertens. 34 ( 2 ): 244 – 252 .
- Tanner , R.M. , Shimbo , D. , Dreisbach , A.W. et al. ( 2015 ). Association between 24-hour blood pressure variability and chronic kidney disease: a cross-sectional analysis of African Americans participating in the Jackson heart study . BMC Nephrol. 16 : 84 .
- Staessen , J.A. , Bieniaszewski , L. , O'Brien , E. et al. ( 1997 ). Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The “Ad Hoc” working group . Hypertension 29 ( 1 Pt 1 ): 30 – 39 .
- Yusuf , S. , Sleight , P. , Pogue , J. et al. ( 2000 ). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients . N. Engl. J. Med. 342 ( 3 ): 145 – 153 .
- Minutolo , R. , Agarwal , R. , Borrelli , S. et al. ( 2011 ). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease . Arch. Intern. Med. 171 ( 12 ): 1090 – 1098 .
- Hermida , R.C. , Ayala , D.E. , Mojon , A. , and Fernandez , J.R. ( 2011 ). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD . J. Am. Soc. Nephrol. 22 ( 12 ): 2313 – 2321 .
- Rahman , M. , Greene , T. , Phillips , R.A. et al. ( 2013 ). A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease . Hypertension 61 ( 1 ): 82 – 88 .
- Liu , L. , Cao , Q. , Guo , Z. , and Dai , Q. ( 2016 ). Continuous positive airway pressure in patients with obstructive sleep Apnea and resistant hypertension: a meta-analysis of randomized controlled trials . J. Clin. Hypertens. (Greenwich) 18 ( 2 ): 153 – 158 .
- Yu , J. , Zhou , Z. , McEvoy , R.D. et al. ( 2017 ). Association of Positive Airway Pressure with Cardiovascular Events and Death in adults with sleep Apnea: a systematic review and meta-analysis . JAMA 318 ( 2 ): 156 – 166 .
- Terracciano , A. , Scuteri , A. , Strait , J. et al. ( 2014 ). Are personality traits associated with white-coat and masked hypertension? J. Hypertens. 32 ( 10 ): 1987 – 1992 ; discussion 92.
- Gorostidi , M. , Sarafidis , P.A. , de la Sierra , A. et al. ( 2013 ). Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5,693-patient cross-sectional analysis from Spain . Am. J. Kidney Dis. 62 ( 2 ): 285 – 294 .
- Pogue , V. , Rahman , M. , Lipkowitz , M. et al. ( 2009 ). Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease . Hypertension 53 ( 1 ): 20 – 27 .
- Iimuro , S. , Imai , E. , Watanabe , T. et al. ( 2013 ). Clinical correlates of ambulatory BP monitoring among patients with CKD . Clin. J. Am. Soc. Nephrol. 8 ( 5 ): 721 – 730 .
- Drawz , P.E. , Alper , A.B. , Anderson , A.H. et al. ( 2016 ). Masked hypertension and elevated Nighttime blood pressure in CKD: prevalence and association with target organ damage . Clin. J. Am. Soc. Nephrol. 11 ( 4 ): 642 – 652 .
- Agarwal , R. , Pappas , M.K. , and Sinha , A.D. ( 2016 ). Masked uncontrolled hypertension in CKD . J. Am. Soc. Nephrol. 27 ( 3 ): 924 – 932 .
- Wang , C. , Zhang , J. , Li , Y. et al. ( 2017 ). Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease . Int. J. Cardiol. 230 : 33 – 39 .
- Kushiro , T. , Kario , K. , Saito , I. et al. ( 2017 ). Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST study . Hypertens. Res. 40 ( 1 ): 87 – 95 .
- Ruzicka , M. , Quinn , R.R. , McFarlane , P. et al. ( 2014 ). Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD . Am. J. Kidney Dis. 63 ( 6 ): 869 – 887 .
- Hiremath , S. ( 2018 ). Towards better blood pressure: do non-pharmacological strategies provide the right path? J. Clin. Hypertens. (Greenwich) 20 ( 3 ): 528 – 531 .
- Aburto , N.J. , Ziolkovska , A. , Hooper , L. et al. ( 2013 ). Effect of lower sodium intake on health: systematic review and meta-analyses . BMJ 346 : f1326 .
- McMahon , E.J. , Bauer , J.D. , Hawley , C.M. et al. ( 2013 ). A randomized trial of dietary sodium restriction in CKD . J. Am. Soc. Nephrol. 24 ( 12 ): 2096 – 2103 .
- Saran , R. , Padilla , R.L. , Gillespie , B.W. et al. ( 2017 ). A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD . Clin. J. Am. Soc. Nephrol. 12 ( 3 ): 399 – 407 .
- Aburto , N.J. , Hanson , S. , Gutierrez , H. et al. ( 2013 ). Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses . BMJ 346 : f1378 .
- Gritter , M. , Vogt , L. , Yeung , S.M.H. et al. ( 2018 ). Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective effects of potassium supplementation in chronic kidney disease . Nephron 140 ( 1 ): 48 – 57 .
- Appel , L.J. , Moore , T.J. , Obarzanek , E. et al. ( 1997 ). A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group . N. Engl. J. Med. 336 ( 16 ): 1117 – 1124 .
- Tyson , C.C. , Lin , P.H. , Corsino , L. et al. ( 2016 ). Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding study . Clin. Kidney J. 9 ( 4 ): 592 – 598 .
- Rebholz , C.M. , Crews , D.C. , Grams , M.E. et al. ( 2016 ). DASH (dietary approaches to stop hypertension) diet and risk of subsequent kidney disease . Am. J. Kidney Dis. 68 ( 6 ): 853 – 861 .
- Roerecke , M. , Kaczorowski , J. , Tobe , S.W. et al. ( 2017 ). The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis . Lancet Public Health 2 ( 2 ): e108 – e120 .
- Dickinson , H.O. , Mason , J.M. , Nicolson , D.J. et al. ( 2006 ). Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials . J. Hypertens. 24 ( 2 ): 215 – 233 .
- Heiwe , S. and Jacobson , S.H. ( 2011 ). Exercise training for adults with chronic kidney disease . Cochrane Database Syst. Rev. 10 : CD003236.
- Cornelissen , V.A. and Smart , N.A. ( 2013 ). Exercise training for blood pressure: a systematic review and meta-analysis . J. Am. Heart Assoc. 2 ( 1 ): e004473 .
- Naci , H. , Salcher-Konrad , M. , Dias , S. et al. ( 2018 ). How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure . Br. J. Sports Med. 2019 Jul; 53 ( 14 ): 859 – 869 . doi: 10.1136/bjsports-2018-099921. Epub 2018 Dec 18.
- Fontana , M. , Asaria , P. , Moraldo , M. et al. ( 2014 ). Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility . Circulation 129 ( 24 ): 2539 – 2546 .
- Ruzicka , M. , Hiremath , S. , Steiner , S. et al. ( 2014 ). What is the feasibility of implementing effective sodium reduction strategies to treat hypertension in primary care settings? A systematic review . J. Hypertens. 32 ( 7 ): 1388 – 1394 ; discussion 94.
- Drewnowski , A. , Rehm , C.D. , Maillot , M. et al. ( 2015 ). The feasibility of meeting the WHO guidelines for sodium and potassium: a cross-national comparison study . BMJ Open 5 ( 3 ): e006625 .
- Rothman , R.L. , Housam , R. , Weiss , H. et al. ( 2006 ). Patient understanding of food labels: the role of literacy and numeracy . Am. J. Prev. Med. 31 ( 5 ): 391 – 398 .
- Taylor , D.M. , Fraser , S.D.S. , Bradley , J.A. et al. ( 2017 ). A systematic review of the prevalence and associations of limited health literacy in CKD . Clin. J. Am. Soc. Nephrol. 12 ( 7 ): 1070 – 1084 .
- Mazarova , A. , Hiremath , S. , Sood , M.M. et al. ( 2017 ). Hemodialysis access choice: impact of health literacy . Health Lit. Res. Pract. 1 ( 3 ): e136 – e144 .
- Ruzicka , M. , Burns , K.D. , and Hiremath , S. ( 2017 ). Precision medicine for hypertension management in chronic kidney disease: relevance of SPRINT for therapeutic targets in non-diabetic renal disease . Can. J. Cardiol. 33 ( 5 ): 611 – 618 .
- Ruzicka , M. and Hiremath , S. ( 2017 ). Intensive blood pressure lowering in chronic kidney disease: the time has come . Curr. Opin. Nephrol. Hypertens. 26 ( 3 ): 197 – 204 .
- ALLHAT AOaCftACRGTAaL-LTtPHAT ( 2002 ). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) . JAMA 288 ( 23 ): 2981 – 2997 .
- Muntner , P. , Anderson , A. , Charleston , J. et al. ( 2010 ). Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study . Am. J. Kidney Dis. 55 ( 3 ): 441 – 451 .
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group ( 2002 ). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) . JAMA 288 ( 23 ): 2981 – 2997 .
- Fried , L.F. , Emanuele , N. , Zhang , J.H. et al. ( 2013 ). Combined angiotensin inhibition for the treatment of diabetic nephropathy . N. Engl. J. Med. 369 ( 20 ): 1892 – 1903 .
- Yusuf , S. , Teo , K.K. , Pogue , J. et al. ( 2008 ). Telmisartan, ramipril, or both in patients at high risk for vascular events . N. Engl. J. Med. 358 ( 15 ): 1547 – 1559 .
- Parving , H.H. , Brenner , B.M. , McMurray , J.J. et al. ( 2012 ). Cardiorenal end points in a trial of aliskiren for type 2 diabetes . N. Engl. J. Med. 367 ( 23 ): 2204 – 2213 .
- Ernst , M.E. , Carter , B.L. , Goerdt , C.J. et al. ( 2006 ). Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure . Hypertension 47 ( 3 ): 352 – 358 .
- Beckett , N.S. , Peters , R. , Fletcher , A.E. et al. ( 2008 ). Treatment of hypertension in patients 80 years of age or older . N. Engl. J. Med. 358 ( 18 ): 1887 – 1898 .
- Jamerson , K. , Weber , M.A. , Bakris , G.L. et al. ( 2008 ). Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients . N. Engl. J. Med. 359 ( 23 ): 2417 – 2428 .
- Lederle , F.A. , Cushman , W.C. , Ferguson , R.E. et al. ( 2016 ). Chlorthalidone versus hydrochlorothiazide: a new kind of veterans affairs cooperative study . Ann. Intern. Med. 165 ( 9 ): 663 – 664 .
- Dhalla , I.A. , Gomes , T. , Yao , Z. et al. ( 2013 ). Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study . Ann. Intern. Med. 158 ( 6 ): 447 – 455 .
- Agarwal , R. , Sinha , A.D. , Pappas , M.K. , and Ammous , F. ( 2014 ). Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study . Am. J. Nephrol. 39 ( 2 ): 171 – 182 .
- Williams , B. , MacDonald , T.M. , Morant , S. et al. ( 2015 ). Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial . Lancet 386 ( 10008 ): 2059 – 2068 .
- Heshka , J. , Ruzicka , M. , Hiremath , S. , and McCormick , B.B. ( 2010 ). Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy . J. Am. Soc. Hypertens. 4 ( 6 ): 295 – 301 .
- Brown , M.J. , Williams , B. , Morant , S.V. et al. ( 2016 ). Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial . Lancet Diabetes Endocrinol. 4 ( 2 ): 136 – 147 .
- Baker , W.L. , Buckley , L.F. , Kelly , M.S. et al. ( 2017 ). Effects of sodium-glucose Cotransporter 2 inhibitors on 24-hour ambulatory blood pressure: a systematic review and meta-analysis . J. Am. Heart Assoc. 6 ( 5 ).
- Zelniker , T.A. , Wiviott , S.D. , Raz , I. et al. ( 2019 ). SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials . Lancet 393 ( 10166 ): 31 – 39 .
- McMurray , J.J. , Packer , M. , Desai , A.S. et al. ( 2014 ). Angiotensin-neprilysin inhibition versus enalapril in heart failure . N. Engl. J. Med. 371 ( 11 ): 993 – 1004 .
- Haynes , R. , Judge , P.K. , Staplin , N. et al. ( 2018 ). Effects of Sacubitril/valsartan versus Irbesartan in patients with chronic kidney disease . Circulation 138 ( 15 ): 1505 – 1514 .
- Oparil , S. and Schmieder , R.E. ( 2015 ). New approaches in the treatment of hypertension . Circ. Res. 116 ( 6 ): 1074 – 1095 .
-
Adson , A.W.
and
Brown , G.E.
(
1934
).
Malignant hypertension: report of case treated by bilateral section of anterior spinal nerve roots from the sixth thoracic to the second lumbar, inclusive
.
J. Am. Med. Assoc.
102
(
14
):
1115
–
1118
.
10.1001/jama.1934.02750140001001 Google Scholar
- Grimson , K.S. ( 1941 ). Total thoracic and partial to Total lumbar Sympathectomy and celiac Ganglionectomy in the treatment of hypertension . Ann. Surg. 114 ( 4 ): 753 – 775 .
- Esler , M.D. , Krum , H. , Sobotka , P.A. et al. ( 2010 ). Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial . Lancet 376 ( 9756 ): 1903 – 1909 .
- Krum , H. , Schlaich , M. , Whitbourn , R. et al. ( 2009 ). Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study . Lancet 373 ( 9671 ): 1275 – 1281 .
- Bhatt , D.L. , Kandzari , D.E. , O'Neill , W.W. et al. ( 2014 ). A controlled trial of renal denervation for resistant hypertension . N. Engl. J. Med. 370 ( 15 ): 1393 – 1401 .
- Howard , J.P. , Shun-Shin , M.J. , Hartley , A. et al. ( 2016 ). Quantifying the 3 biases that Lead to unintentional overestimation of the blood pressure-lowering effect of renal denervation . Circ. Cardiovasc. Qual. Outcomes 9 ( 1 ): 14 – 22 .
- Kandzari , D.E. , Bohm , M. , Mahfoud , F. et al. ( 2018 ). Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial . Lancet 391 ( 10137 ): 2346 – 2355 .
- Townsend , R.R. , Mahfoud , F. , Kandzari , D.E. et al. ( 2017 ). Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial . Lancet 390 ( 10108 ): 2160 – 2170 .
- Logan , A.G. , Diaconita , V. , Ing , D.J. et al. ( 2015 ). Acute renal failure after renal denervation . J. Vasc. Interv. Radiol. 26 ( 3 ): 450 – 451 .
- Kiuchi , M.G. , Mion , D. Jr. , Graciano , M.L. et al. ( 2016 ). Proof of concept study: improvement of echocardiographic parameters after renal sympathetic denervation in CKD refractory hypertensive patients . Int. J. Cardiol. 207 : 6 – 12 .
- Kiuchi , M.G. , Maia , G.L. , de Queiroz Carreira , M.A. et al. ( 2013 ). Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension . Eur. Heart J. 34 ( 28 ): 2114 – 2121 .
- Bisognano , J.D. , Bakris , G. , Nadim , M.K. et al. ( 2011 ). Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial . J. Am. Coll. Cardiol. 58 ( 7 ): 765 – 773 .
- Lobo , M.D. , Ott , C. , Sobotka , P.A. et al. ( 2017 ). Central iliac Arteriovenous anastomosis for uncontrolled hypertension: one-year results from the ROX CONTROL HTN trial . Hypertension 70 ( 6 ): 1099 – 1105 .
- Perry , H.M. Jr. , Davis , B.R. , Price , T.R. et al. ( 2000 ). Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the systolic hypertension in the elderly program (SHEP) . JAMA 284 ( 4 ): 465 – 471 .
- Wright , J.T. Jr. , Bakris , G. , Greene , T. et al. ( 2002 ). Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial . JAMA 288 ( 19 ): 2421 – 2431 .
- Xie , X. , Atkins , E. , Lv , J. et al. ( 2016 ). Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis . Lancet 387 ( 10017 ): 435 – 443 .
- Sundstrom , J. , Arima , H. , Woodward , M. et al. ( 2014 ). Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data . Lancet 384 ( 9943 ): 591 – 598 .
- Cheung , A.K. , Rahman , M. , Reboussin , D.M. et al. ( 2017 ). Effects of intensive BP control in CKD . J. Am. Soc. Nephrol. 28 ( 9 ): 2812 – 2813 .
- Klahr , S. , Levey , A.S. , Beck , G.J. et al. ( 1994 ). The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group . N. Engl. J. Med. 330 ( 13 ): 877 – 884 .
- Ruggenenti , P. , Perna , A. , Loriga , G. et al. ( 2005 ). Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial . Lancet 365 ( 9463 ): 939 – 946 .
- Malhotra , R. , Nguyen , H.A. , Benavente , O. et al. ( 2017 ). Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis . JAMA Intern. Med. 177 ( 10 ): 1498 – 1505 .
- Perkovic , V. and Rodgers , A. ( 2015 ). Redefining blood-pressure targets--SPRINT starts the Marathon . N. Engl. J. Med. 373 ( 22 ): 2175 – 2178 .
- Gerstein , H.C. , Miller , M.E. , Byington , R.P. et al. ( 2008 ). Effects of intensive glucose lowering in type 2 diabetes . N. Engl. J. Med. 358 ( 24 ): 2545 – 2559 .
- Tsujimoto , T. and Kajio , H. ( 2018 ). Benefits of intensive blood pressure treatment in patients with type 2 diabetes mellitus receiving standard but not intensive glycemic control . Hypertension 72 ( 2 ): 323 – 330 .
- Bangalore , S. , Kumar , S. , Lobach , I. , and Messerli , F.H. ( 2011 ). Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials . Circulation 123 ( 24 ): 2799 – 2810 , 9 p following 810.
- Emdin , C.A. , Rahimi , K. , Neal , B. et al. ( 2015 ). Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis . JAMA 313 ( 6 ): 603 – 615 .
- Brunstrom , M. and Carlberg , B. ( 2016 ). Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses . BMJ 352 : i717 .
- Thomopoulos , C. , Parati , G. , and Zanchetti , A. ( 2017 ). Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials . J. Hypertens. 35 ( 5 ): 922 – 944 .
- Bhandari , S. , Ives , N. , Brettell , E.A. et al. ( 2016 ). Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial . Nephrol. Dial. Transplant. 31 ( 2 ): 255 – 261 .
- Nesrallah , G.E. , Mustafa , R.A. , Clark , W.F. et al. ( 2014 ). Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis . CMAJ 186 ( 2 ): 112 – 117 .
- Agarwal , R. , Nissenson , A.R. , Batlle , D. et al. ( 2003 ). Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States . Am. J. Med. 115 ( 4 ): 291 – 297 .
- Agarwal , R. ( 2011 ). Epidemiology of interdialytic ambulatory hypertension and the role of volume excess . Am. J. Nephrol. 34 ( 4 ): 381 – 390 .
- Cocchi , R. , Degli Esposti , E. , Fabbri , A. et al. ( 1999 ). Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study . Nephrol. Dial. Transplant. 14 ( 6 ): 1536 – 1540 .
- Rodby , R.A. , Vonesh , E.F. , and Korbet , S.M. ( 1994 ). Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring . Am. J. Kidney Dis. 23 ( 3 ): 401 – 411 .
- Liu , Y. , Ma , X. , Zheng , J. et al. ( 2017 ). Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials . BMC Nephrol. 18 ( 1 ): 206 .
- Langote , A. , Hiremath , S. , Ruzicka , M. , and McCormick , B.B. ( 2017 ). Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients . PLoS One 12 ( 11 ): e0187269 .
- Covic , A. , Ciumanghel , A.I. , Siriopol , D. et al. ( 2017 ). Value of bioimpedance analysis estimated “dry weight” in maintenance dialysis patients: a systematic review and meta-analysis . Int. Urol. Nephrol. 49 ( 12 ): 2231 – 2245 .
- Woodrow , G. , Oldroyd , B. , Stables , G. et al. ( 2000 ). Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis . Nephrol. Dial. Transplant. 15 ( 6 ): 862 – 866 .
- Paniagua , R. , Ventura , M.D. , Avila-Diaz , M. et al. ( 2009 ). Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients . Perit. Dial. Int. 29 ( 4 ): 422 – 432 .
- Rutkowski , B. , Tam , P. , van der Sande , F.M. et al. ( 2016 ). Low-sodium versus standard-sodium peritoneal dialysis solution in hypertensive patients: a randomized controlled trial . Am. J. Kidney Dis. 67 ( 5 ): 753 – 761 .
- Khandelwal , M. and Oreopoulos , D.G. ( 2004 ). Is there a need for low sodium dialysis solution for peritoneal dialysis patients? Adv. Perit. Dial. 20 : 156 – 162 .
- Zager , P.G. , Nikolic , J. , Brown , R.H. et al. ( 1998 ). “U” curve association of blood pressure and mortality in hemodialysis patients. Medical directors of dialysis clinic, Inc . Kidney Int. 54 ( 2 ): 561 – 569 .
- Kalantar-Zadeh , K. , Block , G. , Humphreys , M.H. , and Kopple , J.D. ( 2003 ). Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients . Kidney Int. 63 ( 3 ): 793 – 808 .
- Agarwal , R. and Sinha , A.D. ( 2009 ). Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis . Hypertension 53 ( 5 ): 860 – 866 .
- Agarwal , R. ( 2010 ). Blood pressure and mortality among hemodialysis patients . Hypertension 55 ( 3 ): 762 – 768 .
- Kotanko , P. , Garg , A.X. , Depner , T. et al. ( 2015 ). Effects of frequent hemodialysis on blood pressure: results from the randomized frequent hemodialysis network trials . Hemodial. Int. 19 ( 3 ): 386 – 401 .
- Hall , Y.N. , Larive , B. , Painter , P. et al. ( 2012 ). Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: frequent hemodialysis network (FHN) randomized trials . Clin. J. Am. Soc. Nephrol. 7 ( 5 ): 782 – 794 .
- Jardine , M.J. , Zuo , L. , Gray , N.A. et al. ( 2017 ). A trial of extending Hemodialysis hours and quality of life . J. Am. Soc. Nephrol. 28 ( 6 ): 1898 – 1911 .
- Daugirdas , J.T. , Greene , T. , Rocco , M.V. et al. ( 2013 ). Effect of frequent hemodialysis on residual kidney function . Kidney Int. 83 ( 5 ): 949 – 958 .
- Suri , R.S. , Larive , B. , Sherer , S. et al. ( 2013 ). Risk of vascular access complications with frequent hemodialysis . J. Am. Soc. Nephrol. 24 ( 3 ): 498 – 505 .
- de Paula , F.M. , Peixoto , A.J. , Pinto , L.V. et al. ( 2004 ). Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients . Kidney Int. 66 ( 3 ): 1232 – 1238 .
- Munoz Mendoza , J. , Bayes , L.Y. , Sun , S. et al. ( 2011 ). Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study . Am. J. Kidney Dis. 58 ( 6 ): 956 – 963 .
- Inrig , J.K. , Molina , C. , D'Silva , K. et al. ( 2015 ). Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study . Am. J. Kidney Dis. 65 ( 3 ): 464 – 473 .
- Takahashi , A. , Takase , H. , Toriyama , T. et al. ( 2006 ). Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study . Nephrol. Dial. Transplant. 21 ( 9 ): 2507 – 2512 .
- Suzuki , H. , Kanno , Y. , Sugahara , S. et al. ( 2008 ). Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial . Am. J. Kidney Dis. 52 ( 3 ): 501 – 506 .
- Iseki , K. , Arima , H. , Kohagura , K. et al. ( 2013 ). Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial . Nephrol. Dial. Transplant. 28 ( 6 ): 1579 – 1589 .
- Tepel , M. , Hopfenmueller , W. , Scholze , A. et al. ( 2008 ). Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients . Nephrol. Dial. Transplant. 23 ( 11 ): 3605 – 3612 .
- Tieu , A. , Velenosi , T.J. , Kucey , A.S. et al. ( 2018 ). Beta-blocker Dialyzability in maintenance Hemodialysis patients: a randomized clinical trial . Clin. J. Am. Soc. Nephrol. 13 ( 4 ): 604 – 611 .
- Agarwal , R. , Sinha , A.D. , Pappas , M.K. et al. ( 2014 ). Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial . Nephrol. Dial. Transplant. 29 ( 3 ): 672 – 681 .
- Weir , M.A. , Dixon , S.N. , Fleet , J.L. et al. ( 2015 ). Beta-blocker dialyzability and mortality in older patients receiving hemodialysis . J. Am. Soc. Nephrol. 26 ( 4 ): 987 – 996 .
- Assimon , M.M. , Brookhart , M.A. , Fine , J.P. et al. ( 2018 ). A comparative study of Carvedilol versus Metoprolol initiation and 1-year mortality among individuals receiving maintenance Hemodialysis . Am. J. Kidney Dis. 72 ( 3 ): 337 – 348 .
- Ruzicka , M. , McCormick , B. , Leenen , F.H. et al. ( 2013 ). Adherence to blood pressure-lowering drugs and resistant hypertension: should trial of direct observation therapy be part of preassessment for renal denervation? Can. J. Cardiol. 29 ( 12 ): 1741 , e1–3.
- Matsumoto , Y. , Mori , Y. , Kageyama , S. et al. ( 2014 ). Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients . J. Am. Coll. Cardiol. 63 ( 6 ): 528 – 536 .
- Lin , C. , Zhang , Q. , Zhang , H. , and Lin , A. ( 2016 ). Long-term effects of low-dose spironolactone on chronic dialysis patients: a randomized placebo-controlled study . J. Clin. Hypertens. (Greenwich) 18 ( 2 ): 121 – 128 .
- Walsh , M. , Manns , B. , Garg , A.X. et al. ( 2015 ). The safety of Eplerenone in Hemodialysis patients: a noninferiority randomized controlled trial . Clin. J. Am. Soc. Nephrol. 10 ( 9 ): 1602 – 1608 .
- Quach , K. , Lvtvyn , L. , Baigent , C. et al. ( 2016 ). The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis . Am. J. Kidney Dis. 68 ( 4 ): 591 – 598 .
- Weir , M.R. , Burgess , E.D. , Cooper , J.E. et al. ( 2015 ). Assessment and management of hypertension in transplant patients . J. Am. Soc. Nephrol. 26 ( 6 ): 1248 – 1260 .
- Kasiske , B.L. , Anjum , S. , Shah , R. et al. ( 2004 ). Hypertension after kidney transplantation . Am. J. Kidney Dis. 43 ( 6 ): 1071 – 1081 .
- Opelz , G. , Wujciak , T. , and Ritz , E. ( 1998 ). Association of chronic kidney graft failure with recipient blood pressure. Collaborative transplant study . Kidney Int. 53 ( 1 ): 217 – 222 .
- Hiremath , S. , Fergusson , D. , Doucette , S. et al. ( 2007 ). Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence . Am. J. Transplant. 7 ( 10 ): 2350 – 2360 .
- Moes , A.D. , Hesselink , D.A. , van den Meiracker , A.H. et al. ( 2017 ). Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with Tacrolimus: a randomized crossover trial . Am. J. Kidney Dis. 69 ( 6 ): 796 – 804 .
- Cross , N.B. , Webster , A.C. , Masson , P. et al. ( 2009 ). Antihypertensive treatment for kidney transplant recipients . Cochrane Database Syst. Rev. 3 : CD003598.
- Hiremath , S. , Fergusson , D.A. , Fergusson , N. et al. ( 2017 ). Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials . Am. J. Kidney Dis. 69 ( 1 ): 78 – 86 .
- Ibrahim , H.N. , Jackson , S. , Connaire , J. et al. ( 2013 ). Angiotensin II blockade in kidney transplant recipients . J. Am. Soc. Nephrol. 24 ( 2 ): 320 – 327 .
- Philipp , T. , Martinez , F. , Geiger , H. et al. ( 2010 ). Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET . Nephrol. Dial. Transplant. 25 ( 3 ): 967 – 976 .
- Williams , B. , Mancia , G. , Spiering , W. et al. ( 2018 ). 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension . J. Hypertens. 36 ( 10 ): 1953 – 2041 .
- Whelton , P.K. , Carey , R.M. , Aronow , W.S. et al. ( 2018 ). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, Evaluation, and Management of High Blood Pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines . Hypertension 71 ( 6 ): e13 – e115 .
- Nerenberg , K.A. , Zarnke , K.B. , Leung , A.A. et al. ( 2018 ). Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children . Can. J. Cardiol. 34 ( 5 ): 506 – 525 .
- Iimuro , S. , Imai , E. , Watanabe , T. et al. ( 2013 ). Chronic Kidney Disease Japan Cohort Study Group . Clin. J. Am. Soc. Nephrol. 8 ( 5 ): 721 – 730 .
- Minutolo , R. , Gabbai , F.B. , Agarwal , R. et al. ( 2014 ). Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study . Am. J. Kidney Dis. 64 ( 5 ): 744 – 752 .
- Scheppach , J.B. , Raff , U. , Toncar , S. et al. ( 2018 ). Blood pressure pattern and target organ damage in patients with chronic kidney disease . Hypertension. 72 : 929 – 936 .
- Inrig et al. ( 2015 ). Am J Kidney Dis. 2015 Mar; 65 ( 3 ): 464 – 73 . doi: 10.1053/j.ajkd.2014.10.021. Epub 2014 Dec 17.